Individualized Prediction for Risk of Recurrence in Stage I/II Melanoma Patients With Negative Sentinel Lymph Node

Individualized Prediction for Risk of Recurrence in Stage I/II Melanoma Patients With Negative Sentinel Lymph Node

ABSTRACT Background Despite the favorable prognosis of AJCC stage I/II melanoma patients, up to 20%–30% will develop metastases. Our objective is to predict long‐term risk (probability) of recurrence in early‐stage melanoma patients. Methods A Risk Score to predict long‐term recurrence was developed...

Full description

Saved in:
Bibliographic Details
Main Authors: Shu‐Ching Chang, Kristel Lourdault, Gary L. Grunkemeier, Douglas A. Hanes, Shih‐Ting Chiu, Stacey Stern, Richard Essner
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Cancer Medicine
Subjects:
Gompertz model
negative sentinel lymph node
risk of recurrence
stage I/II melanoma
Online Access:https://doi.org/10.1002/cam4.70441
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.70441

Similar Items